In prognostic assessment, longitudinal monitoring of the glutathione redox status (GSH/GSSG ratio), lactate levels, and IL-6 concentrations allows for quantitative characterization of spatiotemporally dynamic tumor redox stress and inflammatory microenvironments. The gene discussed is IL6; the disease is neoplasm.